Learn more

UNIV VIRGINIA PATENT FOUNDATION

Overview
  • Total Patents
    715
  • GoodIP Patent Rank
    2,803
  • Filing trend
    ⇩ 30.0%
About

UNIV VIRGINIA PATENT FOUNDATION has a total of 715 patent applications. It decreased the IP activity by 30.0%. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are UNIV NEBRASKA, MAYO FOUND MEDICAL EDUCATION & RES and FUJIFILM RI PHARMA CO LTD.

Patent filings per year

Chart showing UNIV VIRGINIA PATENT FOUNDATIONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kovatchev Boris P 49
#2 Breton Marc D 47
#3 Patek Stephen D 35
#4 Macdonald Timothy L 27
#5 Meyer Craig H 22
#6 Johnson Bankole A 22
#7 Hunt Donald F 20
#8 Hossack John A 18
#9 Shabanowitz Jeffrey 17
#10 Lynch Kevin R 17

Latest patents

Publication Filing date Title
US2021071268A1 Methods and compositions for diagnosing and treating prostate cancer based on long noncoding rna overlapping the lck gene that regulates prostate cancer cell growth
WO2021081105A1 Methods, systems, and computer readable media for utilizing a therapeutic ultrasound device to perform mitral valve decalcification
WO2021076897A1 Compositions and methods for producing enhanced immune responses and rapid antibody production
WO2021076985A1 Ceramide ratios as predictive and therapeutic biomarkers for leukemias
WO2021071830A1 Modulating lymphatic vessels in neurological disease
WO2021062383A1 Compositions and methods for preventing and/or reducing weight gain and associated conditions
WO2021055889A1 Devices, systems, and methods for magnetic resonance imaging (mri)-guided procedures
WO2021041317A1 Ddx17 and nlrc4 targeting for inflammatory diseases
US2021054382A1 Methods and compositions for diagnosing and treating prostate cancer based on long noncoding rna overlapping the lck gene that regulates prostate cancer cell growth
WO2021026119A1 TRANSCRIPTION FACTOR NtERF221 AND METHODS OF USING THE SAME
WO2021026074A1 Bispecific antibody targeting of t regulatory cells for treatment of inflammatory conditions
WO2021021716A1 Compositions and methods for inhibiting neointimal formation
US2021028818A1 Asynchronous stream mote
WO2021016249A2 Target peptides for cancer therapy and diagnostics
WO2021016263A1 Cysteine binding compositions and methods of use thereof
WO2021007485A1 System and method for online domain adaptation of models for hypoglycemia prediction in type 1 diabetes
US2021002650A1 Compositions and methods for treating alzheimer's disease
WO2020257299A1 Compositions and methods for preparing regio- and stereoselective alicyclic alkene isotopologues and stereoisotopomers
WO2020252031A1 System and method of accelerating polymer fiber stabilization via irradiation treatment
WO2020247498A1 System, method and computer readable medium for improving symptom treatment in regards to the patient and caregiver dyad